首页|Humboldt-University and Berlin Institute of Health Reports Findings in Artificia l Intelligence (The Global Evolution and Impact of Systems Biology and Artificia l Intelligence in Stem Cell Research and Therapeutics Development: A Scoping Rev iew)
Humboldt-University and Berlin Institute of Health Reports Findings in Artificia l Intelligence (The Global Evolution and Impact of Systems Biology and Artificia l Intelligence in Stem Cell Research and Therapeutics Development: A Scoping Rev iew)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Artificial Intelligenc e is the subject of a report. According to news originating from Berlin, Germany , by NewsRx correspondents, research stated, “Advanced bioinformatics analysis, such as systems biology (SysBio) and artificial intelligence (AI) approaches, in cluding machine learning (ML) and deep learning (DL), is increasingly present in stem cell (SC) research. An approximate timeline on these developments and thei r global impact is still lacking.” Our news journalists obtained a quote from the research from the Humboldt-Univer sity and Berlin Institute of Health, “We conducted a scoping review on the contr ibution of SysBio and AI analysis to SC research and therapy development based o n literature published in PubMed between 2000 and 2024. We identified an 8-10-fo ld increase in research output related to all three search terms between 2000 an d 2021, with a 10-fold increase in AI-related production since 2010. Use of SysB io and AI still predominates in preclinical basic research with increasing use i n clinically oriented translational medicine since 2010. SysBio- and AI-related research was found all over the globe, with SysBio output led by the United Stat es (US, n=1487), United Kingdom (UK, n=1094), Germany (n=355), The Netherlands ( n=339), Russia (n=215), and France (n=149), while for AI-related research the US (n=853) and UK (n=258) take a strong lead, followed by Switzerland (n=69), The Netherlands (n=37), and Germany (n=19). The US and UK are most active in SCs pub lications related to AI/ML and AI/DL. The prominent use of SysBio in ESC researc h was recently overtaken by prominent use of AI in iPSC and MSC research.”
BerlinGermanyEuropeArtificial Inte lligenceDrugs and TherapiesEmerging TechnologiesHealth and MedicineMachi ne LearningStem Cell Research
NETL
NSTL
